Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Vormehr

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Annual Review of Medicine|January 30, 2019
Harnessing Tumor Mutations for Truly Individualized Cancer VaccinesMathias Vormehr, Özlem Türeci, Ugur Sahin
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 2, 2019
Personalized Neo-Epitope Vaccines for Cancer TreatmentMathias Vormehr, Mustafa Diken, Özlem Türeci, et al.
Current Opinion in Immunology|December 31, 2015
Mutanome directed cancer immunotherapyMathias Vormehr, Mustafa Diken, Sebastian Boegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Targeting the Heterogeneity of Cancer with Individualized Neoepitope VaccinesÖzlem Türeci, Mathias Vormehr, Mustafa Diken, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the MutanomeMustafa Diken, Mathias Vormehr, Christian Grunwitz, et al.
Journal of Immunology Research|February 5, 2016
Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor VaccinationMathias Vormehr, Barbara Schrörs, Sebastian Boegel, et al.
Human Vaccines & Immunotherapeutics|August 29, 2017
CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer ImmunotherapyLena M Kranz, Jan D Beck, Christian Grunwitz, et al.
Molecular Cancer|April 16, 2021
mRNA therapeutics in cancer immunotherapyJan D Beck, Daniel Reidenbach, Nadja Salomon, et al.
Cancer Immunology Research|June 17, 2024
RNA-encoded Interleukin 2 with Extended Bioavailability Amplifies RNA Vaccine-Induced Antitumor T-cell ImmunityDaniel Peters, Lena M Kranz, David Eisel, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, GermanyMustafa Diken, Sebastian Boegel, Christian Grunwitz, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Annual Review of Medicine|January 30, 2019
Harnessing Tumor Mutations for Truly Individualized Cancer VaccinesMathias Vormehr, Özlem Türeci, Ugur Sahin
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 2, 2019
Personalized Neo-Epitope Vaccines for Cancer TreatmentMathias Vormehr, Mustafa Diken, Özlem Türeci, et al.
Current Opinion in Immunology|December 31, 2015
Mutanome directed cancer immunotherapyMathias Vormehr, Mustafa Diken, Sebastian Boegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Targeting the Heterogeneity of Cancer with Individualized Neoepitope VaccinesÖzlem Türeci, Mathias Vormehr, Mustafa Diken, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the MutanomeMustafa Diken, Mathias Vormehr, Christian Grunwitz, et al.
Journal of Immunology Research|February 5, 2016
Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor VaccinationMathias Vormehr, Barbara Schrörs, Sebastian Boegel, et al.
Human Vaccines & Immunotherapeutics|August 29, 2017
CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer ImmunotherapyLena M Kranz, Jan D Beck, Christian Grunwitz, et al.
Molecular Cancer|April 16, 2021
mRNA therapeutics in cancer immunotherapyJan D Beck, Daniel Reidenbach, Nadja Salomon, et al.
Cancer Immunology Research|June 17, 2024
RNA-encoded Interleukin 2 with Extended Bioavailability Amplifies RNA Vaccine-Induced Antitumor T-cell ImmunityDaniel Peters, Lena M Kranz, David Eisel, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, GermanyMustafa Diken, Sebastian Boegel, Christian Grunwitz, et al.
Pageof 4